Have a personal or library account? Click to login
Stereotactic radiosurgery of prostate cancer – dose distribution for VMAT and CyberKnife techniques Cover

Stereotactic radiosurgery of prostate cancer – dose distribution for VMAT and CyberKnife techniques

Open Access
|Jul 2016

Abstract

New capabilities of biomedical accelerators allow for very precise depositing of the radiation dose and imaging verification during the therapy. In addition, computer algorithms calculating dose distributions are taking into account the increasing number of physical effects. Therefore, administration of high dose fractionation, which is consistent with radiobiology used in oncology, becomes safer and safer. Stereotactic radiosurgery (SRS), which is very precise irradiation with high dose fractionation is increasingly widespread use in radiotherapy of prostate cancer. For this purpose different biomedical accelerators are used. The aim of this study is to compare dose distributions for two techniques: VMAT and CyberKnife. Statistical analysis was performed for the two groups of patients treated by VMAT technique (25 patients), and CyberKnife technique (15 patients). The analysis shows that the dose distributions are comparable, both in the treated area (prostate) and in the critical organs (rectum, urinary bladder, femoral heads). The results show that stereotactic radiosurgery of prostate cancer can be carried out on CyberKnife accelerator as well as on the classical accelerator with the use of VMAT technique.

DOI: https://doi.org/10.1515/pjmpe-2016-0007 | Journal eISSN: 1898-0309 | Journal ISSN: 1425-4689
Language: English
Page range: 35 - 40
Published on: Jul 2, 2016
Published by: Polish Society of Medical Physics
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Krzysztof Ślosarek, Wojciech Osewski, Aleksandra Grządziel, Małgorzata Stąpór-Fudzińska, Marta Szlag, published by Polish Society of Medical Physics
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.